Top Markets
Coin of the day
SCHOTT Pharma AG & Co. KGaA SCHOTT Pharma AG & Co. KGaA

SCHOTT Pharma AG & Co. KGaA

1SXP
Rangering i aksjer #4100
Globally, SCHOTT Pharma AG & Co. KGaA specializes in the development,... Globally, SCHOTT Pharma AG & Co. KGaA specializes in the development, manufacturing, and distribution of sophisticated containment and delivery systems specifically designed for injectable pharmaceuticals, catering to the needs of the pharmaceutical and biotechnology sectors. Their comprehensive product portfolio encompasses both polymer and glass options across various crucial categories, including syringes, ampoules, vials, and cartridges. Their extensive range of syringes features specialized solutions such as the syriQ series (including BioPure for biologics and silicone-free variants) crafted from glass, ideal for vaccines and sensitive biologics, alongside the versatile polymer-based SCHOTT TOPPAC line, tailored for applications from cosmetic treatments and deep-cold storage to infusion therapy and delicate drugs. For cartridges, SCHOTT Pharma provides the cartriQ pharmaceutical glass series, designed for peptide, protein, and large-volume injectables, as well as double-chamber options for lyophilized drugs and break-resistant variants, supplemented by their TopLine and StandardLine offerings. Vial solutions include the adaptiQ pharmaceutical glass vial for general injectables, the EVERIC range focused on drug stability (pure, care for pH, strong & smooth for filling lines), SCHOTT Type I plus for specific formulations, and TopLyo to prevent fogging in lyophilized drugs, alongside their TopLine and StandardLine vials. The ampoule selection features easyOPC for convenient opening, Anti-Counterfeiting ampoules for enhanced security, and their dependable StandardLine options. Established in 1884 and based in Mainz, Germany, SCHOTT Pharma AG & Co. KGaA functions as a subsidiary of Schott Glaswerke Beteiligungs- Und Export Gmbh.
Aksjekurs
$27.64
Markedsverdi
$4.16B
Endring (1 dag)
1.97%
Endring (1 år)
1.44%
Land
DE
Handel SCHOTT Pharma AG & Co. KGaA (1SXP)

Kategori

Inntekter for SCHOTT Pharma AG & Co. KGaA (1SXP)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til SCHOTT Pharma AG & Co. KGaA er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for SCHOTT Pharma AG & Co. KGaA fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$11.03B -
US
$34.74B -
FR
- -
JP
$20.84B -
US
- -
CH